-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Reiterates Outperform on Oruka Therapeutics, Maintains $165 Price Target

Benzinga·09/24/2026 12:40:56
Listen to the news
Wedbush analyst Martin Fan reiterates Oruka Therapeutics (NASDAQ:ORKA) with a Outperform and maintains $165 price target.